Product image
InVivoMAb anti-Influenza A virus NP
BE0159
ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Other Application
Product group Antibodies
ReactivityVirus
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-Influenza A virus NP
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDH16-L10-4R5 (HB-65)
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- ReactivityVirus
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Phosphorylation controls RNA binding and transcription by the influenza virus polymerase. Dawson AR et al., 2020 Sep, PLoS PathogRead more
- A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice. Freyn AW et al., 2020 Jul 8, Mol TherRead more
- Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus. Nigg PE et al., 2015 Dec 11, J Biol ChemRead more
- Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice. Leung YHC et al., 2014 Sep, J Gen VirolRead more
- Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture. van Baalen CA et al., 2014 May, J Clin MicrobiolRead more
- Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections. Haynes L et al., 2012 Nov 15, J ImmunolRead more